NEW YORK — JULY 6, 2023 — IAVI is pleased to announce a new award has been granted by the German government to help support the late-stage development of a promising tuberculosis (TB) vaccine candidate, MTBVAC.

BCG is a live bacterial vaccine, of limited effectiveness for tuberculosis, but it's the only one we've got. However, scientists in the TB Immunology group at Trinity College Dublin and St. James's Hospital have provided fresh insights into the behaviour of a crucial cell in vaccine mechanisms, which may offer a fresh target for scientists seeking to improve vaccine efficacy.

RESIST-TB released its July 2023 newsletter with the latest updates and research publications on drug-resistant TB.

Before SARS-CoV-2, the virus that causes COVID-19, spread across the world in 2020, tuberculosis was responsible for more deaths globally than any other infectious disease. But thanks to targeted public health efforts in the U.S. and globally, tuberculosis cases had been steadily falling for decades.

It started in early 2022, with a feeling of general body weakness and sickness, then came the weight loss, fever and night sweats that alarmed Laura Amollo. Several visits to health centres in the Eastlands area of Nairobi left both patient and health workers puzzled.

India’s political leadership has made tremendous commitment to end tuberculosis in India. But the question remains: Can India end tuberculosis without innovation, new strategies, and technologies backed by evidence?

100 sponsored registrations will be offered to civil society members, individuals involved in efforts to address lung health, and survivors of TB. Deadline for application: 25 July 2023

The first clinical trial of a three-month TB treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.

A guide for affected community and civil society organizations, national TB programs and policy-makers in eastern Europe and central Asia

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.